Deciphering hematological malignancies for improved disease management
SOPHiA Myeloid Solution is a CE-IVD marked molecular diagnostic application that bundles a capture-based target enrichment kit with the analytical power of SOPHiA™ AI and full access to SOPHiA DDM® platform.
The solution was designed to accurately characterize the complex mutational landscape of major hematological disorders such as myelodysplastic syndromes, myeloproliferative neoplasms, and leukemia.
Benefits of the solution
Detection of all types of genomic alterations (i.e SNVs, Indels and CNVs) in all the genes of the panel associated with hematological disorders
Proven clinical-grade analytical performance
Excellent coverage uniformity in all the genes of the panel, unlocking unmatched detection of complex variants in genes such as CEBPA, FLT3, ASXL1 and CALR
Compatible with market-leading sequencing platforms without impact on performance. The gene panel can also be adapted according to experts' needs
1: MDS: myelodysplastic syndromes
2: MPN: myeloproliferative neoplasms